Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Appian A | APPN | Jan 23, 2025 | 33.69 | +2.59 |
Apple | AAPL | Jan 23, 2025 | 223.66 | -0.08 |
Apple Hospitality REIT | APLE | Jan 23, 2025 | 15.26 | +0.53 |
Applied Digital | APLD | Jan 23, 2025 | 9.27 | -3.84 |
Applied DNA Sciences | APDN | Jan 23, 2025 | 0.20 | +12.99 |
Applied Industrial Technologies | AIT | Jan 23, 2025 | 261.52 | -0.08 |
Applied Materials | AMAT | Jan 23, 2025 | 190.70 | -2.46 |
Applied Optoelectronics | AAOI | Jan 23, 2025 | 32.50 | -2.40 |
Applied Therapeutics | APLT | Jan 23, 2025 | 0.61 | -2.98 |
Applovin A | APP | Jan 23, 2025 | 362.52 | +0.22 |
AppTech Payments | APCX | Jan 23, 2025 | 0.42 | -2.13 |
Aprea Therapeutics | APRE | Jan 23, 2025 | 4.07 | +1.50 |
AptarGroup | ATR | Jan 23, 2025 | 159.62 | +0.35 |
Aptevo Therapeutics | APVO | Jan 23, 2025 | 4.61 | +2.44 |
Aptiv | APTV | Jan 23, 2025 | 63.92 | +1.90 |
Aptorum Group A | APM | Jan 23, 2025 | 1.24 | +10.27 |
Aptose Biosciences | APTO | Jan 23, 2025 | 0.21 | -1.68 |
APx Acquisition I Unit | APXIU | Jan 23, 2025 | 11.55 | 0.00 |
Apyx Medical | APYX | Jan 23, 2025 | 1.53 | +0.66 |
Aqua Metals | AQMS | Jan 23, 2025 | 1.91 | -1.55 |
AquaBounty Technologies | AQB | Jan 23, 2025 | 0.90 | +2.43 |
Aquaron Acquisition | AQU | Jan 23, 2025 | 11.44 | +0.35 |
Aquaron Acquisition Units | AQUNU | Jan 23, 2025 | 12.10 | -4.79 |
Aquestive Therapeutics | AQST | Jan 23, 2025 | 3.13 | -0.32 |
Aramark | ARMK | Jan 23, 2025 | 38.41 | +1.08 |
ARB IOT Group | ARBB | Jan 23, 2025 | 0.51 | -3.15 |
Arbe Robotics | ARBE | Jan 23, 2025 | 2.86 | -4.98 |
Arbor Realty Trust | ABR | Jan 23, 2025 | 13.31 | +0.08 |
Arbor Realty Trust D Pref | ABR-D | Jan 23, 2025 | 18.32 | -0.62 |
Arbor Realty Trust E Pref | ABR-E | Jan 23, 2025 | 18.05 | -0.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.